| Building genetic medicine: Breast cancer, technology, and the comparative politics of health care S Parthasarathy MIT press, 2012 | 201 | 2012 |
| Breaking the expertise barrier: understanding activist strategies in science and technology policy domains S Parthasarathy Science and Public Policy 37 (5), 355-367, 2010 | 116 | 2010 |
| Patent Politics: Life Forms, Markets, and the Public Interest in the United States and Europe S Parthasarathy University of Chicago Press, 2017 | 109 | 2017 |
| Architectures of Genetic Medicine Comparing Genetic Testing for Breast Cancer in the USA and the UK S Parthasarathy Social studies of science 35 (1), 5-40, 2005 | 71 | 2005 |
| Regulating risk: Defining genetic privacy in the United States and Britain S Parthasarathy Science, Technology & Human Values 29 (3), 332-352, 2004 | 43 | 2004 |
| Knowledge is power: genetic testing for breast cancer and patient activism in the United States and Britain S Parthasarathy | 29 | 2003 |
| Whose knowledge? What values? The comparative politics of patenting life forms in the United States and Europe S Parthasarathy Policy Sciences 44, 267-288, 2011 | 26 | 2011 |
| What’s in the Chatterbox? Large Language Models, Why They Matter, and What We Should Do About Them SP Johanna Okerlund, Evan Klasky, Aditya Middha, Sujin Kim, Hannah Rosenfeld ... https://stpp.fordschool.umich.edu/research/research-report/whats-in-the …, 2022 | 23* | 2022 |
| Assessing the social impact of direct-to-consumer genetic testing: understanding sociotechnical architectures S Parthasarathy Genetics in Medicine 12 (9), 544-547, 2010 | 21 | 2010 |
| A public good? Geoengineering and intellectual property S Parthasarathy, C Avery, N Hedberg, J Mannisto, M Maguire Ann Arbor, MI: Gerald R. Ford School of Public Policy, University of Michigan, 2010 | 19 | 2010 |
| The patent is political: the consequences of patenting the BRCA genes in Britain S Parthasarathy Public Health Genomics 8 (4), 235-242, 2005 | 19 | 2005 |
| Use the patent system to regulate gene editing S Parthasarathy Nature 562 (7728), 486-488, 2018 | 17 | 2018 |
| Governance Lessons for CRISPR/Cas9 from the Missed Opportunities of Asilomar S Parthasarathy Ethics in Biology, Engineering and Medicine: An International Journal 6 (3-4 …, 2015 | 16 | 2015 |
| Innovation Policy, Structural Inequality, and COVID-19 S Parthasarathy Democratic Theory 7 (2), 104-109, 2020 | 14 | 2020 |
| More testing alone will not get us out of this pandemic S Parthasarathy Nature 585, 2020 | 11 | 2020 |
| Cameras in the classroom: Facial recognition technology in schools C Galligan, H Rosenfeld, M Kleinman, S Parthasarathy | 10 | 2020 |
| Grassroots Innovation Systems for the Post-Carbon World: Promoting Economic Democracy, Environmental Sustainability, and the Public Interest Parthasarathy Brook. L. Rev. 82, 761, 2016 | 10 | 2016 |
| Historical survey of media coverage of biotechnology in the United States 1970 to 1996 BV Lewenstein, T Allaman, S Parthasarathy annual meeting of the Association for Education in Journalism and Mass …, 1998 | 9 | 1998 |
| Comparing life form patent controversies in Europe and the United States S Parthasarathy Science and Democracy: Making Knowledge and Making Power in The Biosciences …, 2015 | 6* | 2015 |
| Reconceptualizing Technology Transfer: The Challenge of Building and International System of Genetic Testing for Breast Cancer S Parthasarathy Shaping Science and Technology Policy: The Next Generation of Research, 2005 | 6 | 2005 |
Molly KleinmanManaging Director, Science, Technology, and Public Policy program, University of Michigan在 umich.edu 的电子邮件经过验证
